The metabolism of APAP has been well-studied and the distributions of its metabolites in the plasma and urine of humans are well-documented[4, 6, 7], as are the hepatic values in mice and rats[8]
10.2337/dc13-2760 9
InBody BIA is not equivalent to DEXA in absolute accuracy, but it is validated for tracking longitudinal changes, which is exactly what GLP-1 monitoring requires
In an interim analysis of an ongoing global trial, semaglutide resolved steatohepatitis in 63% of patients and reduced liver fibrosis, while also promoting weight loss and improving metabolic health in people with advanced fatty liver disease
Trials also reveal improved metabolic parameters, like waist circumference, blood pressure, and cholesterol levels
Keeping a simple food log for just two weeks per month helps many patients notice eating pattern drift before significant regain occurs